Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Currently, cigarette smoking remains a global epidemic, with approximately one billion tobacco smokers worldwide, despite declines in use. Vaping products have become popular alternatives in recent years to conventional cigarettes. There has been a perception that vaping serves as a "healthier" alternative and has been increasing across all age groups, especially among teenagers and young adults. Vaping and its additives have been shown to have various implications across organ systems, including pulmonary and cardiovascular systems. Meanwhile, additional research efforts are needed to gain insight into the pathophysiology of vaping on cardiovascular disease onset, progression, and outcomes. In order to better understand the body of literature available on the association between vaping and cardiovascular function, a systematic review was conducted, which included case studies of patients engaged in vaping at the time of developing a cardiovascular event. A systematic review was conducted with a total of 20 patients. Only case studies were included to assess the cardiovascular outcomes that were reported with vaping using either nicotine, non-nicotine, or tetrahydrocannabinol (THC)-containing products. Patients were excluded if they orally consumed the vaping liquid and did not smoke the product. Fourteen of the 20 patients assessed were males (70%), five females (25%), and one unspecified sex (5%). The patients varied in age from 13 to 70 years of age, with a mean age of 27.6 years. Vaping history duration ranged from two days to eight years, with a mean of 22.8 months. Fourteen of the 20 patients reported using nicotine-containing vape devices, with an additional two using THC-containing vape products, three using both nicotine and THC-containing vape devices, and one non-nicotine-containing vape device. The results demonstrated that eight of 20 patients presented with chest pain or discomfort and 10 were found in sudden cardiac arrest. Upon resuscitation from cardiac arrest, a variety of arrhythmias were seen, including ventricular tachycardia, ventricular fibrillation, polymorphic ventricular tachycardia, atrial fibrillation, and a prolonged QT segment arrhythmia. The results suggest that vaping likely negatively impacts the cardiovascular system. Further research is warranted, especially as the popularity of vaping continues to rise among younger populations. As vaping continues to rise in popularity, particularly among younger populations, further research is warranted to elucidate its long-term cardiovascular impact.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11841693PMC
http://dx.doi.org/10.7759/cureus.77780DOI Listing

Publication Analysis

Top Keywords

vaping cardiovascular
12
systematic review
12
vaping
12
cardiovascular
8
cardiovascular system
8
review conducted
8
case studies
8
fourteen patients
8
vape devices
8
thc-containing vape
8

Similar Publications

Introduction: Vaping among children and young people (CYP) has increased globally over the past decade, with rates stabilising in the UK in recent years. Factors such as curiosity, social influence, stress management and attractive flavours contribute to its popularity. Although the long-term health impacts are uncertain, vaping poses risks including nicotine dependence, cardiovascular and respiratory issues, and cognitive impairment, though evidence on long-term effects is still emerging.

View Article and Find Full Text PDF

Background: E-cigarettes are promoted for smoking cessation due to their having lower toxicity than cigarettes, but they are often used recreationally and linked to cardiovascular, respiratory, and mental health risks. Clinicians must understand usage patterns and influencing factors to guide patients in reducing or quitting their use.

Methods: We surveyed consecutive cardiac inpatients admitted to the University of Ottawa Heart Institute between November 2019 and May 2020.

View Article and Find Full Text PDF

Hexahydrocannabinol, a hydrogenated derivative of cannabinol, first came to the Czech Toxicological Information Centre (TIC) following reports of poisonings in May 2022. We conducted a retrospective observational study examining self-reported cases of hexahydrocannabinol and hexahydrocannabiphorol exposure reported to the TIC from May 17, 2022, to April 30, 2024. Of 236 cases reported, 40 (17%) were excluded.

View Article and Find Full Text PDF

Introduction: Health warning labels (HWLs) are used across several regulatory spaces to warn consumers about potentially harmful products. The study goal was to assess US adults' public opinions about HWL policies on social media in general, and for commercial tobacco/nicotine products specifically, in response to a call from the US Surgeon General on HWL policies on social media. This study examined support by political party affiliation.

View Article and Find Full Text PDF

Why We Need Greater, Not Less, Access to Reduced-Risk Nicotine Products.

Cureus

August 2025

Scientific Affairs, HAYPP Limited, London, GBR.

Cigarette smoking is the leading preventable cause of death and disease. Prolonged and repeated inhalational exposure to the chemical toxicants found in cigarette smoke is a known cause of cardiovascular disease, chronic lung disease, and cancer. Novel nicotine products, including e‑cigarettes and tobacco‑free nicotine pouches, reduce exposure to toxicants among those who smoke and switch to their use, reducing the risk of smoking‑related disease.

View Article and Find Full Text PDF